FNGR · Insider Trading
FingerMotion, Inc. Common Stock
Every open-market purchase and sale reported by FNGR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-19 | Christopher Vincent Polimeni | CFO | Buy | +13,500 | +$2.47K |
| 2026-10-19 | Jolie Kahn | CEO | Buy | +15,000 | +$2.55K |
| 2026-04-23 | Martin Chung-Wen Shen | CEO | Buy | +1,000 | +$880 |
| 2025-12-29 | Yew Poh Leong | Director | Buy | −10,000 | −$15.15K |
| 2025-12-23 | Yew Hon Lee | CFO | Sell | −8,000 | −$12.00K |
| 2025-12-08 | Yew Poh Leong | Director | Buy | −10,000 | −$13.50K |
| 2025-11-24 | Yew Poh Leong | Director | Buy | −10,000 | −$13.50K |
| 2025-10-29 | Yew Poh Leong | Director | Buy | −10,000 | −$15.50K |
| 2025-09-11 | Yew Hon Lee | CFO | Sell | −9,000 | −$16.05K |
| 2025-07-29 | Yew Hon Lee | CFO | Sell | −12,542 | −$22.32K |
| 2025-07-25 | Yew Hon Lee | CFO | Sell | −4,000 | −$6.24K |
| 2023-09-14 | Martin Chung-Wen Shen | CEO | MIXED | +46,356 | −$5 |
| 2023-09-14 | Yew Hon Lee | CFO | MIXED | +44,542 | −$5 |
| 2023-09-05 | Yew Poh Leong | Director | Sell | −12,500 | −$71.25K |
| 2023-08-31 | Yew Poh Leong | Director | Sell | −2,176 | −$11.97K |
| 2023-07-31 | Yew Poh Leong | Director | Sell | −7,824 | −$45.32K |
| 2023-07-28 | Yew Poh Leong | Director | Sell | −5,000 | −$26.38K |
| 2023-07-24 | Yew Poh Leong | Director | Sell | −2,500 | −$10.75K |
| 2023-07-19 | Yew Poh Leong | Director | Sell | −2,500 | −$14.12K |
| 2023-07-05 | Li Li | GM of Issuer's affiliate | Buy | +1,000,000 | +$1.00K |
| 2023-07-05 | Li Li | GM of Issuer's affiliate | Buy | +1,200,000 | +$240.00K |
| 2023-06-28 | Yew Poh Leong | Director | Sell | −2,500 | −$10.50K |
| 2023-06-28 | Yew Poh Leong | Director | Sell | −12,500 | −$31.88K |
| 2023-06-28 | Yew Poh Leong | Director | Sell | −2,500 | −$5.75K |
| 2023-03-01 | Yang Yeat Choe | 10%+ Owner | A | +96,000 deriv. | — |
| 2023-03-01 | Chee Ming Cheong | 10%+ Owner | Sell | −100,000 | −$250.00K |
| 2023-03-01 | Chee Ming Cheong | 10%+ Owner | Sell | −280,000 | −$400.60K |
| 2022-05-03 | Michael K H Chan | Director | A | +78,500 deriv. | — |
| 2022-05-03 | Michael K H Chan | Director | Buy | +150,000 | +$150.00K |
| 2022-05-03 | Michael K H Chan | Director | Buy | +100,000 | +$100 |
| 2022-04-27 | Martin Chung-Wen Shen | CEO | Buy | +5,000 | +$10.10K |
| 2021-12-30 | Yew Poh Leong | Director | A | +78,500 deriv. | — |
| 2021-12-30 | Yew Hon Lee | CFO | A | +221,000 deriv. | — |
| 2021-12-30 | Yew Poh Leong | Director | Buy | +250,000 | +$250 |
| 2021-12-30 | Martin Chung-Wen Shen | CEO | A | +230,000 deriv. | — |
| 2021-12-30 | Eng Ho Ng | Director | A | +63,000 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Martin Chung-Wen Shen | CEO | 752,356 | $84.79K |
| Yew Hon Lee | CFO | 461,000 | $51.95K |
| Yew Poh Leong | Director | 165,000 | $18.60K |
| Jolie Kahn | CEO | 15,000 | $1.69K |
| Christopher Vincent Polimeni | CFO | 13,500 | $1.52K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the FNGR quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.